How is drug policy developed? Members of the Pompidou Group

research platform from 17 European countries have studied this

question, taking into account differing national political contexts,

the influence of international conventions and drug strategies at

European level, the evolution of scientific knowledge, and treatment

of drug addiction in the most broad sense of the word.

This work in part provides a reply to the question whether countries opt for an

integrated policy on substances, or for a separate policy for each substance. This

publication also attempts to identify to what extent civil society, practice and

science influence the formulation of drug policy.